Valamehr Bahram
- SEC CIK
- 0001748177
In the past year, 3 open-market sale filings worth $168.1K and no purchases.
Current role at each company
- FATE Fate Therapeutics IncPresident and CEOas of Aug 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $168.1K
- 3 filings
- Net
- −$168.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Valamehr Bahram as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)4:01 PM ET | Aug 4 | 1 day | Valamehr BahramPresident and CEO | SSale | −43.9K | $2.46 | −$108.1K | −6.9%591.8K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Valamehr BahramPresident and CEO | SSale | −28.9K | $1.88 | −$54.4K | −4.4%635.8K after | |
| Jan 12, 2026 (view filing) | Jan 9 | 3 days | Valamehr BahramPresident and CEO | SSale | −5.19K | $1.07 | −$5.55K | −1.5%329.7K after | |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Valamehr BahramPresident and CEO | SSale | −14.5K | $1.06 | −$15.3K | −4.1%334.9K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Valamehr BahramPresident and CEO | SSale | −8.71K | $1.54 | −$13.4K | −2.4%349.4K after | |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Valamehr BahramChief R&D Officer | SSale | −11.3K | $4.38 | −$49.4K | −6.7%158.1K after | |
| Jan 11, 2023 (view filing) | Jan 10 | 1 day | Valamehr BahramChief R&D Officer | SSale | −10.9K | $5.24 | −$57.2K | −6.1%168.9K after | |
| Jul 8, 2022 (view filing) | Jul 7 | 1 day | Valamehr BahramChief R&D Officer | SSale | −17.2K | $30.23 | −$518.7K | −8.7%179.8K after | |
| Jul 7, 2022 (view filing) | Jul 6 | 1 day | Valamehr BahramChief R&D Officer | SSale | −7.84K | $30.07 | −$235.8K | −4.2%179.8K after | |
| Mar 15, 2022 (view filing) | Mar 14 | 1 day | Valamehr BahramChief R&D Officer | SSale | −25.0K | $31.07 | −$776.7K | −12.2%179.8K after | 5 lots |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Valamehr BahramChief R&D Officer | SSale | −4.57K | $48.50 | −$221.7K | −3.0%146.5K after | 2 lots |
| Jan 12, 2022 (view filing) | Jan 10 | 2 days | Valamehr BahramChief R&D Officer | SSale | −5.60K | $46.38 | −$259.6K | −3.6%151.1K after | 2 lots |
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Valamehr BahramChief R&D Officer | SSale | −25.0K | $47.66 | −$1.19M | −13.8%156.7K after | 5 lots |
| Sep 14, 2021 (view filing) | Sep 13 | 1 day | Valamehr BahramChief Development Officer | SSale | −25.0K | $66.29 | −$1.66M | −20.7%95.7K after | 3 lots |